138 related articles for article (PubMed ID: 11431023)
1. Anti-cancer drug success emerges from molecular biology origins.
Pestell K
Trends Pharmacol Sci; 2001 Jul; 22(7):342. PubMed ID: 11431023
[No Abstract] [Full Text] [Related]
2. Targeting cancers with tyrosine kinase inhibitors: lessons learned from chronic myeloid leukaemia.
Mughal TI; Goldman JM
Clin Med (Lond); 2006; 6(6):526-8. PubMed ID: 17228548
[No Abstract] [Full Text] [Related]
3. New drugs in acute myeloid leukemia.
Grever MR
Clin Adv Hematol Oncol; 2003 Aug; 1(8):456-9. PubMed ID: 16258431
[No Abstract] [Full Text] [Related]
4. Imatinib mesylate.
Am J Health Syst Pharm; 2001 Dec; 58(23):2241-2. PubMed ID: 11765724
[No Abstract] [Full Text] [Related]
5. Molecularly targeted therapy in myeloid leukaemias.
Craddock C
Clin Med (Lond); 2007 Dec; 7(6):632-5. PubMed ID: 18193718
[No Abstract] [Full Text] [Related]
6. STI571 (glivec-tm): a new paradigm for the development of innovative therapies in onco-hematology?
Gambacorti C
Tumori; 2001; 87(6):S10-2. PubMed ID: 11989608
[No Abstract] [Full Text] [Related]
7. Sunitinib for imatinib-resistant GIST.
Joensuu H
Lancet; 2006 Oct; 368(9544):1303-4. PubMed ID: 17046443
[No Abstract] [Full Text] [Related]
8. Taking aim at Ewing's sarcoma: is KIT a target and will imatinib work?
Druker BJ
J Natl Cancer Inst; 2002 Nov; 94(22):1660-1. PubMed ID: 12441314
[No Abstract] [Full Text] [Related]
9. [Consensus on the medical treatment of gastrointestinal stromal tumors].
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):875-7. PubMed ID: 18396652
[No Abstract] [Full Text] [Related]
10. A Bcr/Abl kinase antagonist for chronic myelogenous leukemia: a promising path for progress emerges.
Sausville EA
J Natl Cancer Inst; 1999 Jan; 91(2):102-3. PubMed ID: 9923844
[No Abstract] [Full Text] [Related]
11. Chronic myeloid leukemia. Sceptical scientists.
Druker BJ
Lancet; 2001 Dec; 358 Suppl():S11. PubMed ID: 11784560
[No Abstract] [Full Text] [Related]
12. From the Food and Drug Administration.
Schwetz BA
JAMA; 2001 Jul; 286(1):35. PubMed ID: 11434814
[No Abstract] [Full Text] [Related]
13. Imatinib: resisting the resistance.
Rothberg PG
Leuk Res; 2003 Nov; 27(11):977-8. PubMed ID: 12859989
[No Abstract] [Full Text] [Related]
14. Imatinib therapy for patients with chronic myelogenous leukemia: are patients living longer?
DeAngelo DJ; Ritz J
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):1-3. PubMed ID: 14734443
[No Abstract] [Full Text] [Related]
15. Complete cytogenetic and molecular response to treatment with imatinib mesylate for philadelphia chromosome positive acute myeloid leukemia with multilineage dysplasia.
Ueda K; Horiike S; Zen K; Misawa S; Taniwaki M
Leuk Lymphoma; 2006 Sep; 47(9):1967-9. PubMed ID: 17065015
[No Abstract] [Full Text] [Related]
16. Is telomerase a player in chronic phase chronic myeloid leukemia, disease progression and imatinib resistance?
White DL
Leuk Lymphoma; 2008 Jun; 49(6):1022-3. PubMed ID: 18452091
[No Abstract] [Full Text] [Related]
17. Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target?
Malagola M; Martinelli G; Rondoni M; Paolini S; Gaitani S; Arpinati M; Piccaluga PP; Amabile M; Basi C; Ottaviani E; Candoni A; Gottardi E; Cilloni D; Bocchia M; Saglio G; Lauria F; Fanin R; Visani G; Marrè MC; Maderna M; Rancati F; Vinaccia V; Russo D; Baccarani M
Blood; 2005 Jan; 105(2):904; author reply 905. PubMed ID: 15632213
[No Abstract] [Full Text] [Related]
18. 3. Imatinib therapy in chronic myelogenous leukemia.
Jinnai I
Intern Med; 2007; 46(2):95-7. PubMed ID: 17220607
[No Abstract] [Full Text] [Related]
19. Kinase inhibitors translate lab discoveries into exciting new cures for cancers.
Mohindru M; Verma A
Indian J Pediatr; 2004 Aug; 71(8):713-8. PubMed ID: 15345872
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitor STI-571: the new wonder drug of cancer therapy.
Haydon RC; Zhou L; He TC
Cancer Biol Ther; 2004 Apr; 3(4):393-4. PubMed ID: 15004535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
